Seed VC · Belgium

Bioqube Ventures

Active

What they invest in

We help science succeed by turning discoveries into transformative medicines. We invest in companies developing first- or best-in-class therapeutics to address major unmet medical needs.

Who they back

DeepTechHealthtechBiotechSeedSeries A

Business models

biotech_therapeutics

Customer segments

Researchers

Geography

Europe, US

Recent investments

  • CatalYm
  • SynOx Therapeutics
  • Primmune Therapeutics

The people who write checks

9 partners on file at Bioqube Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Bioqube Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Bioqube Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Belgium
Last known deal
Jun 2020
Portfolio last checked
Oct 6, 2026
Website
www.bioqubeventures.com ↗

Other firms investing in DeepTech

See all investors

Is Bioqube Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Bioqube Ventures is one of them, and we'll tell you exactly where they sit in your top 100.